Who has invested in Synata Bio?

True North Venture Partners are named among the investors backing Synata Bio.

Synata Bio Funding: $78M Raised, Series A (2024)

Synata Bio funding overview

Synata Bio is based in Warrenville, IL. Synata Bio has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2024. The round record for Synata Bio runs through 2024; nothing later has been disclosed. Investors on record include True North Venture Partners.

Synata Bio at a glance

Total raised: $78M
Latest round: Series A
Latest round date: November 2024
Headquarters: Warrenville, IL
Notable investors: True North Venture Partners

Frequently asked about Synata Bio funding

How much has Synata Bio raised?: Synata Bio has raised $78M in total disclosed funding across the rounds on record.
Who has invested in Synata Bio?: True North Venture Partners are named among the investors backing Synata Bio.
What was the latest Synata Bio funding round?: The most recent disclosed round is a Series A, announced in November 2024.
Where is Synata Bio based?: Synata Bio is based in Warrenville, IL.
When did Synata Bio last raise?: The last disclosed Synata Bio round closed in November 2024 at Series A.

Synata Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Warrenville below to benchmark round size and investor mix.

Synata Bio Funding: $78M Raised, Series A (2024)

Synata Bio funding overview

Synata Bio at a glance

Frequently asked about Synata Bio funding

Companies related to Synata Bio (30)

Browse related funding lists (3)